GlassScriptPhysician profile
Karen D Johnson
NPI 1386636090
$15,761.32
in general payments reported to CMS, 2019-2025
26 companies · $1,569 in 2025
The $1,569 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,763 · 2021: $260 · 2022: $318 · 2023: $601 · 2024: $546 · 2025: $1,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,469 · Travel and Lodging: $1,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,468.70 |
| Travel and Lodging | $1,248.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $13,122.27 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Aptima |
| Intuitive Surgical, INC. | $1,248.07 | 2025 | |
| Coopersurgical, INC. | $271.36 | 2019-2025 | Mara Console, Paragard T 380a |
| Abbvie INC. | $194.43 | 2019-2023 | |
| Astellas Pharma US INC | $130.46 | 2023-2025 | Veozah, Myrbetriq |
| Myriad Women'S Health, INC. | $121.88 | 2023 | Myrisk |
| Cleerly, INC. | $83.29 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Exact Sciences Corporation | $71.05 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Ibsa Pharma INC. | $64.62 | 2021-2022 | |
| Dexcom, INC. | $48.11 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $47.24 | 2025 | Zepbound |
| Sumitomo Pharma America, INC. | $42.90 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $41.76 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.17 | 2024 | Cuvitru |
| Inspire Medical Systems, INC. | $25.00 | 2025 | Inspire |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $24.56 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.19 | 2019 | |
| Roche Diagnostics Corporation | $23.37 | 2019 | |
| Exeltis, USA INC. | $21.76 | 2024 | Slynd |
| Covidien LP | $21.17 | 2019 | |
| Dysis Medical, INC. | $17.32 | 2022 | |
| Cook Medical LLC | $17.17 | 2025 | Zilver Vena |
| Millicent US INC | $16.94 | 2025 | Femlyv |
| Merck Sharp & Dohme LLC | $16.04 | 2019 | |
| Xeris Pharmaceuticals, INC. | $15.28 | 2025 | Keveyis |
| Minerva Surgical, INC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.